Cargando…

Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?()

Skin infections by Mycobacterium marinum are quite rare in our environment and, therefore, little studied. The majority of the lesions appear three weeks after traumas in aquariums, beaches and fish tanks. Lymph node drainage and systematization of the disease are rare and most lesions disappear in...

Descripción completa

Detalles Bibliográficos
Autores principales: Neugebauer, Maria Gertrudes Fernandes Pereira, Neugebauer, Samuel Antônio, Almeida Junior, Hiram Larangeira, Mota, Laís Marques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323709/
https://www.ncbi.nlm.nih.gov/pubmed/25672310
http://dx.doi.org/10.1590/abd1806-4841.20153090
_version_ 1782356583854899200
author Neugebauer, Maria Gertrudes Fernandes Pereira
Neugebauer, Samuel Antônio
Almeida Junior, Hiram Larangeira
Mota, Laís Marques
author_facet Neugebauer, Maria Gertrudes Fernandes Pereira
Neugebauer, Samuel Antônio
Almeida Junior, Hiram Larangeira
Mota, Laís Marques
author_sort Neugebauer, Maria Gertrudes Fernandes Pereira
collection PubMed
description Skin infections by Mycobacterium marinum are quite rare in our environment and, therefore, little studied. The majority of the lesions appear three weeks after traumas in aquariums, beaches and fish tanks. Lymph node drainage and systematization of the disease are rare and most lesions disappear in about three years. This case aims to show the effectiveness of the treatment used (lymecycline 150 mg/orally/day). This medication may be a new therapeutic option for the treatment of Mycobacterium marinum.
format Online
Article
Text
id pubmed-4323709
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-43237092015-02-20 Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?() Neugebauer, Maria Gertrudes Fernandes Pereira Neugebauer, Samuel Antônio Almeida Junior, Hiram Larangeira Mota, Laís Marques An Bras Dermatol Case Report Skin infections by Mycobacterium marinum are quite rare in our environment and, therefore, little studied. The majority of the lesions appear three weeks after traumas in aquariums, beaches and fish tanks. Lymph node drainage and systematization of the disease are rare and most lesions disappear in about three years. This case aims to show the effectiveness of the treatment used (lymecycline 150 mg/orally/day). This medication may be a new therapeutic option for the treatment of Mycobacterium marinum. Sociedade Brasileira de Dermatologia 2015 /pmc/articles/PMC4323709/ /pubmed/25672310 http://dx.doi.org/10.1590/abd1806-4841.20153090 Text en ©2015 by Anais Brasileiros de Dermatologia http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Neugebauer, Maria Gertrudes Fernandes Pereira
Neugebauer, Samuel Antônio
Almeida Junior, Hiram Larangeira
Mota, Laís Marques
Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?()
title Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?()
title_full Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?()
title_fullStr Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?()
title_full_unstemmed Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?()
title_short Treatment of Mycobacterium marinum with lymecycline: new therapeutic alternative?()
title_sort treatment of mycobacterium marinum with lymecycline: new therapeutic alternative?()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323709/
https://www.ncbi.nlm.nih.gov/pubmed/25672310
http://dx.doi.org/10.1590/abd1806-4841.20153090
work_keys_str_mv AT neugebauermariagertrudesfernandespereira treatmentofmycobacteriummarinumwithlymecyclinenewtherapeuticalternative
AT neugebauersamuelantonio treatmentofmycobacteriummarinumwithlymecyclinenewtherapeuticalternative
AT almeidajuniorhiramlarangeira treatmentofmycobacteriummarinumwithlymecyclinenewtherapeuticalternative
AT motalaismarques treatmentofmycobacteriummarinumwithlymecyclinenewtherapeuticalternative